Sequential liquid biopsy analysis of the NOSTRA-Feasibility study (HER2+/ER-) shows correlation between ctDNA clearance and pathological complete response after neoadjuvant chemotherapy and dual targeted therapy ISRCTN 17170034, Closed, Sponsor: University of Birmingham

View at publisher Summarise with VIRAT
Authors: DW Rea, Andrew David Beggs, Elena Efstathiou, JD Stockton, R.M. Worledge, Cristina Escribano-Gonzalez, E. Turner, Sarah J. Pirrie, H. Cain, D. Cameron, D. Dodwell, L. Haywood
+8 more Helena Margaret Earl, Robert C. Stein, K. Herring, M. MacKenzie, Andreas Makris, C. Gaunt, Elizabeth Southgate, N. Morelli
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Fields of Study & Subjects

Cancer Genomics and Diagnostics HER2/EGFR in Cancer Research BRCA gene mutations in cancer

Publication details

Journal / source
European Journal of Cancer
Volume
237
Pages
116516–116516
Publication date
1 March 2026
Language
EN